ArticlePulmonary circulation2023

Management of pulmonary hypertension associated with valvular heart disease with angiotensin-receptor neprilysin inhibitor.

Hyeon-Ju Ryoo Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.